Our in vitro findings showed that statins, well-known HMGCR inhibitors, reduced FoxM1 expression, indicating that statins could be novel inhibitors to reduce FoxM1 in HCC. The gene discussed is HMGCR; the disease is hepatocellular carcinoma.